A novel measure of drug benefit-risk assessment based on Scale Loss Score.
作者： Gaelle Saint-Hilary , Veronique Robert , Mauro Gasparini , Thomas Jaki , Pavel Mozgunov
关键词:
摘要: … quantitative approaches is multicriteria decision analysis (… testing the methodology, the main results indicated a fairly strong … Since the mapping is not far from an identity transformation, …
sagepub.com
figshare.com
sci-hub.se 参考文章(27)
Richard Nixon, Christoph Dierig, Shahrul Mt-Isa, Isabelle Stöckert, Thaison Tong, Silvia Kuhls, Gemma Hodgson, John Pears, Ed Waddingham, Kimberley Hockley, Andrew Thomson, A case study using the PrOACT-URL and BRAT frameworks for structured benefit risk assessment. Biometrical Journal. ,vol. 58, pp. 8- 27 ,(2016) , 10.1002/BIMJ.201300248
Shahrul Mt-Isa, Mario Ouwens, Veronique Robert, Martin Gebel, Alexander Schacht, Ian Hirsch, Structured Benefit-risk assessment: a review of key publications and initiatives on frameworks and methodologies Pharmaceutical Statistics. ,vol. 15, pp. 324- 332 ,(2016) , 10.1002/PST.1690
Lydie Marcelon, Thomas Verstraeten, Geraldine Dominiak-Felden, François Simondon, Quantitative benefit–risk assessment by MCDA of the quadrivalent HPV vaccine for preventing anal cancer in males Expert Review of Vaccines. ,vol. 15, pp. 139- 148 ,(2016) , 10.1586/14760584.2016.1107480
Usha Gupta, Menka Verma, Placebo in clinical trials. Perspectives in Clinical Research. ,vol. 4, pp. 49- 52 ,(2013) , 10.4103/2229-3485.106383
J.G. Norstrom, The use of precautionary loss functions in risk analysis IEEE Transactions on Reliability. ,vol. 45, pp. 400- 403 ,(1996) , 10.1109/24.536992
D A Hughes, A M Bayoumi, M Pirmohamed, Current Assessment of Risk–Benefit by Regulators: Is It Time to Introduce Decision Analyses? Clinical Pharmacology & Therapeutics. ,vol. 82, pp. 123- 127 ,(2007) , 10.1038/SJ.CLPT.6100240
Kevin Marsh, Tereza Lanitis, David Neasham, Panagiotis Orfanos, Jaime Caro, Assessing the value of healthcare interventions using multi-criteria decision analysis: a review of the literature. PharmacoEconomics. ,vol. 32, pp. 345- 365 ,(2014) , 10.1007/S40273-014-0135-0
Tommi Tervonen, Gert van Valkenhoef, Erik Buskens, Hans L. Hillege, Douwe Postmus, A stochastic multicriteria model for evidence-based decision making in drug benefit-risk analysis. Statistics in Medicine. ,vol. 30, pp. 1419- 1428 ,(2011) , 10.1002/SIM.4194
Christy Chuang-Stein, Richard Entsuah, Yili Pritchett, Measures for Conducting Comparative Benefit: Risk Assessment Drug Information Journal. ,vol. 42, pp. 223- 233 ,(2008) , 10.1177/009286150804200304
Filip Mussen, Sam Salek, Stuart Walker, None, A quantitative approach to benefit-risk assessment of medicines - part 1: the development of a new model using multi-criteria decision analysis. Pharmacoepidemiology and Drug Safety. ,vol. 16, ,(2007) , 10.1002/PDS.1435